OKLAHOMA
CITY, June 17, 2024 /PRNewswire/ -- Progentec
Diagnostics, a leader in diagnostic and digital technologies
for management of autoimmune diseases, announced today that
Bernard R. Rubin, DO, MPH
(FACR, FACP), seasoned rheumatology and immunology expert, has
joined Progentec's leadership team as Chief Medical Officer. Dr.
Rubin is one of the foremost experts in the world of immunology,
with a distinguished track record in autoimmune diseases and
rheumatology. His immense wealth of experience and knowledge will
support Progentec in its mission to improve health outcomes for
people living with autoimmune diseases.
Dr. Rubin is a board-certified clinician and an educator with
expertise in systemic lupus erythematosus, rheumatoid arthritis,
and other autoimmune rheumatic conditions. He has participated in
numerous clinical trials, published several articles and abstracts,
and started two rheumatology fellowships dedicated to educating and
developing young trainees into successful clinicians. He has worked
in key leadership positions both in academia and industry, having
held positions as the Division Chief of Rheumatology at Henry Ford
Hospital, Clinical Professor of Medicine at Wayne State University School of Medicine, and
served as the Chief of Rheumatology at the University of North Texas Health Science Center in
Fort Worth, Texas for over twenty
years. Dr. Rubin recently retired as senior medical director at
GSK.
Dr. Rubin chaired the American Osteopathic Association Bureau of
Research from 1999-2002. He was named researcher of the year in
2000 by the American College of Osteopathic Internists and was also
awarded fellowship. Dr Rubin has served on the ethics committee,
professional meetings committee and annual planning committee for
the American College of Rheumatology plus having recently served on
the board of directors of the Rheumatology Research Foundation.
Dr. Rubin has been recognized by Best Doctors in America and
named a Super Doctor in Texas and
a Top Doc in Detroit.
"We are thrilled to welcome Dr. Rubin to our team," said
Mohan Purushothaman, Chief
Executive Officer, Progentec. "His proven leadership and strategic
insights will undoubtedly strengthen our efforts, further
positioning Progentec as an innovative leader in the autoimmune
space."
About Progentec Diagnostics, Inc.
Progentec is committed to improving access and health outcomes for
patients in therapeutic areas with a high level of unmet need by
combining clinically validated diagnostic interventions with
state-of-the-art digital and virtual technologies. Through
collaborations with research institutions and health practitioners
worldwide, Progentec is working to reduce mortality and morbidity
while improving care management and service delivery for chronic
health conditions.
Contact:
Georg Armstrong
405-216-4818 Ext.106
corpcomms@progentec.com
Related Links: https://www.progentec.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/progentec-diagnostics-announces-appointment-of-immunology-expert-dr-bernard-rubin-302174569.html
SOURCE Progentec Diagnostics, Inc.